Drug discovery services for biotech and pharmaceutical companies, including chemistry, biophysics, pharmacology, and DMPK.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Evotec
A
Drug discovery and preclinical development services, focusing on scientific excellence and proprietary technology platforms.
GenoScreen
B
Molecular diagnostic services and research and development for pharmaceutical and biotechnology industries.
ERBC
A
Preclinical research services for drug, chemical, and food product development, including toxicology and efficacy modeling.
Initiatives identified among leaders
Définition d'objectifs de réduction d'émissions de gaz à effet de serre
“Evotec définit des objectifs de réduction d'émissi...” - EvotecRevalorisation salariale systématique après congé maternité ou adoption.
“ERBC Baugy s’engage à revaloriser systématiquement...” - ERBCMise en place d'un système de gouvernance pour la gestion de l'environnement et du développement durable
“Evotec met en place un système de gouvernance pour...” - Evotec42% of similar organizations communicate on CSR issues
+539 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports